FOUSE JACQUALYN A 1405288 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 2505.0 | 17.92 | 0.11 | 0.0 | Direct | Common Stock | INCYTE CORP | code A | 13978.0 | 223.09 (INCY) |
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 23900.0 | 20.31 | 4.3 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 117684.0 | 55.58 (AGIO) |
| 2023-06-30 | 2023-06-28 | 2023-06-30 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 10718.0 | 9.11 | 1.93 | 28.36 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 106966.0 | 55.58 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-09 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 8391.0 | 6.74 | 1.5 | 22.99 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 116075.0 | 55.89 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 17500.0 | 14.06 | 3.13 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 124466.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-24 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 10722.0 | 7.66 | 1.92 | 21.64 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 129253.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 23900.0 | 17.07 | 4.28 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 139975.0 | 55.89 (AGIO) |
| 2024-04-10 | 2024-04-08 | 2024-04-10 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 7791.0 | 5.37 | 1.39 | 27.55 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 137396.0 | 56.19 (AGIO) |
| 2024-04-10 | 2024-04-08 | 2024-04-08 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 15934.0 | 10.97 | 2.84 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 145187.0 | 56.19 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 18958.0 | 100.0 | 3.41 | 26.56 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 18958.0 | 55.58 (AGIO) |
| 2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 3388.0 | 100.0 | 0.61 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 3388.0 | 55.58 (AGIO) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Fouse Jacqualyn A | DIRECTOR | acq | 11294.0 | 100.0 | 0.51 | 61.44 | Direct | Non Qualified Stock Option (Right To Buy) | INCYTE CORP | code A | 11294.0 | 223.09 (INCY) |
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 23900.0 | 50.0 | 4.3 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 23900.0 | 55.58 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 17500.0 | 100.0 | 3.13 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 23900.0 | 100.0 | 4.28 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-04-10 | 2024-04-08 | 2024-04-08 | 4 | Fouse Jacqualyn A | DIRECTOR | dsp | 15934.0 | 50.0 | 2.84 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 15933.0 | 56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)